These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39521354)
1. Unveiling the potential of pulmonary surfactant-based nanocarriers for protein inhalation therapy. Shah KA; Razzaq A; You B; Dormocara A; Iqbal H; Cui JH Eur J Pharm Biopharm; 2024 Dec; 205():114574. PubMed ID: 39521354 [TBL] [Abstract][Full Text] [Related]
2. Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres. Liang D; Walker J; Schwendeman PS; Chandrashekar A; Ackermann R; Olsen KF; Beck-Broichsitter M; Schwendeman SP Drug Deliv Transl Res; 2025 Jan; 15(1):185-202. PubMed ID: 38643259 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
4. Bioactive dextran-based scaffolds from emulsion templates co-stabilized by poly(lactic-co-glycolic acid) nanocarriers. Ducrocq M; Rinaldi A; Halgand B; Veziers J; Guihard P; Boury F; Debuigne A Colloids Surf B Biointerfaces; 2025 Jan; 245():114342. PubMed ID: 39486376 [TBL] [Abstract][Full Text] [Related]
5. Delivery and short-term maternal and fetal safety of vaginally administered PEG-PLGA nanoparticles. Irvin-Choy NS; Nelson KM; Gleghorn JP; Day ES Drug Deliv Transl Res; 2023 Dec; 13(12):3003-3013. PubMed ID: 37365402 [TBL] [Abstract][Full Text] [Related]
6. Combination of DMDD with Nanoparticles Effective Against Diabetic Kidney Disease in vitro. Huang XM; Guo YX; Pang QL; Yan XY; Yan H; Li JY; Tang GL; Jiang HX; Zhang HL Int J Nanomedicine; 2024; 19():12439-12460. PubMed ID: 39611006 [TBL] [Abstract][Full Text] [Related]
7. Development of erythromycin loaded PLGA nanoparticles for improved drug efficacy and sustained release against bacterial infections and biofilm formation. Mayattu K; Rajwade J; Ghormade V Microb Pathog; 2024 Dec; 197():107083. PubMed ID: 39454804 [TBL] [Abstract][Full Text] [Related]
8. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Walker E; Osborn DA Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182 [TBL] [Abstract][Full Text] [Related]
14. Poly-tannic acid coated PLGA nanoparticle decorated with antimicrobial peptide for synergistic bacteria treatment and infectious wound healing promotion. Guo M; Ruan M; Wu J; Ye J; Wang C; Guo Z; Chen W; Wang L; Wu K; Du S; Han N; Lu Y Colloids Surf B Biointerfaces; 2025 Jan; 245():114217. PubMed ID: 39255747 [TBL] [Abstract][Full Text] [Related]
15. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610 [TBL] [Abstract][Full Text] [Related]
16. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease. Redfern J; Tu Q; Hyun K; Hollings MA; Hafiz N; Zwack C; Free C; Perel P; Chow CK Cochrane Database Syst Rev; 2024 Mar; 3(3):CD011851. PubMed ID: 38533994 [TBL] [Abstract][Full Text] [Related]